Explore Applications, Posters and Videos
See MaxCyte Electroporation Technology in Action
Applications
- Clinical-scale NK Cell Engineering Using mRNA Electroporation for the Development of Novel Cell-based Mono- and Combination Immunotherapies
- Case Study: Multiplex CRISPR-mediated Gene Editing Towards the Creation of a Universal CAR T Cell
- Case Study: Multi-gene Knockdown for Improved Therapeutic Efficacy
- Gene Knock-in via Homology-directed Repair in Human iPSCs
- Case Study: Ex Vivo Gene Correction in X-CGD Patient Stem Cells
- Developing an Adoptive Cell Therapy Against AML
- Case Study: CRISPR mRNA & RNP Delivery
- Case Study: Advancing an HIV Clinical Program for CCR5 Gene Disruption
- Translation of NK Cell CAR Therapy to the Clinic: Critical Role of Performance & Clinical-scalability
- Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma
- CRISPR Electroporation of T Cells Improves Treatment in Patients with Refractory Cancer
Posters
- Bolstering Therapeutic Efficacy and Speed to Clinic Using Non-viral T- & NK-cell Engineering
- Advancing Next Generation Cell and Gene Therapies to the Clinic Using Non-viral, Scalable Engineering and Genome Modification of Human Primary Cells, Stem Cells and iPSCs
- Advancing Cellular Therapies Using Clinically Scalable Engineering of T Cells and NK Cells
- Achieving Therapeutic Efficacy with a High Performance, Electroporation-based Cellular Engineering Technology
Videos
- R 1000 - Propelling your Program from Concept to Clinic
- Case Study: CRISPR-engineered T cells in patients with refractory cancer
- Bolstering Therapeutic Efficacy and Speed to Clinic Using Non-viral T- & NK-cell Engineering
- Advancing Cell and Gene Therapies to the Clinic Using Non-viral Engineering and Genome Modification